Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-08-19

Clinical Trial Update: Efficacy and Safety of 1-week Triple Therapy With Ilaprazole for the Eradication of Helicobacter Pylori [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated the efficacy and safety of a 1-week triple therapy including ilaprazole for eradicating Helicobacter pylori; the study has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ilaprazole (ilaprazole)

Snippet

Sponsor: Livzon Pharmaceutical Group Inc. | Conditions: Helicobacter Pylori Eradication | Phase 4 | Status: COMPLETED